Dundee spinout Exscientia is continuing a busy fundraising year with a filing for an IPO in the US and a $35m concurrent private placement.

Exscientia, a UK-based drug discovery technology spinout of University of Dundee, filed for an initial public offering in the US on Friday, using a customary $100m placeholder amount.
The spinout has not yet determined how many American Depositary Shares it will issue, or at what price, but has secured a commitment from Bill and Melinda Gates Foundation to raise $35m in a concurrent private placement.
Founded in 2012, Exscientia has created an artificial intelligence-based end-to-end target identification,…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
email
Linked in